Human apolipoprotein E: The Alzheimer's disease connection

FASEB Journal

Volumn 10, Issue 13, 1996, Pages 1485-1494

  Weisgraber, Karl H ^a   Mahley, Robert W ^a  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

A peptide; cytoskeleton; microtubules; neurite outgrowth; neurodegenerative disease; protein structure

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; CHOLESTEROL TRANSPORT; DEGENERATIVE DISEASE; GENETIC HETEROGENEITY; GENETIC RISK; HUMAN; HUMAN CELL; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MICROTUBULE; NERVE FIBER GROWTH; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

EID: 0029844205     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.13.8940294     Document Type: Review

References (58)

1. Mahley, R. W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240, 622-630
2. Weisgraber, K. H. (1994) Apolipoprotein E: Structure-function relationships. Adv. Protein Chem. 45, 249-302
3. Weisgraber, K. H., Pitas, R. E., and Mahley, R. W. (1994) Lipoproteins, neurobiology, and Alzheimer's disease: Structure and function of apolipoprotein E. Can. Opin. Struct. Biol. 4, 507-515
4. Mahley, R. W., Nathan, B. P., Bellosta, S., and Pitas, R. E. (1995) Apolipoprotein E: Impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr. Opin. Lipidol. 6, 86-91
5. Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., and Weisgraber, K. H. (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262, 14352-14360
6. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993) Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981
7. Corder, E.H., Saundere, A.M., Strittmatter.W.J., Schmechel, D.E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923
8. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
9. Selkoe, D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498
10. Roses, A. D. (1995) On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp. Neurol. 132, 149-156
11. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature (London) 359, 325-327
12. Haass, C., and Selkoe, D. J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042
13. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166
14. Wisniewski, T., and Frangione, B. (1992) Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238
15. Crowther, R. A. (1993) Tau protein and paired helical filaments of Alzheimer's disease. Curr. Opin. Struct. Biol. 3, 202-206
16. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., and Roses, A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653
17. Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D., and Schellenberg, G. D. (1995) A familial Alzheimer's disease locus on chromosome 1. Science. 269, 970-973
18. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., and St. George-Hyslop, P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (London) 375, 754-760
19. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Huletle, C.,Crain, B., Goldgaber, D., and Roses, A. D. (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472
20. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Jr., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., Gusella, J. F., Small, G. W., Roses, A. D., Pericak-Vance, M. A., and Haines, J. L. (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45, 1323-1328
21. Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., Jr., and Weisgraber, K. H. (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains J. Biol. Chem. 263, 6240-6248
22. Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C.-S. C., and Lindgren, F. T. (1988) Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J. Biol. Chem. 263, 6249-6258
23. Innerarily, T. L., Friedlander, E. J., Rall, S. C., Jr., Weisgraber, K. H., and Mahley, R. W. (1983) The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments J. Biol. Chem. 258, 12341-12347
24. Weisgraber, K. H. (1990) Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112 J. Lipid Res. 31, 1503-1511
25. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., and Agard, D. A. (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252, 1817-1822
26. Dong, L.-M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., and Agard, D. A. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol. Chem. 269, 22358-22365
27. 4 in humans. J. Clin. Invest. 78, 815-821
28. Steinmetz, A., Jakobs, C., Motzny, S., and Kaffarnik, H. (1989) Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis 9, 405-411
29. Davignon, J., Gregg, R. E., and Sing, C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21
30. Dong, L.-M., and Weisgraber, K. H. (1996) Human apolipoprotein E4 domain interaction: Arginine-61 and glutamic acid-255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271, 19053-19057
31. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L-M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102
32. LaDu, M. J., Falduto, M. T., Manelli, A. M., Reanion, C. A., Getz, G. S., and Frail, D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23403-23406
33. Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., Roses, A. D., and Strillmatter, W. J. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J. Clin. Invest. 94, 860-869
34. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature (London) 372, 92-94
35. Wisniewski, T., Castaño, E. M., Golabek, A., Vogel, T., and Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035
36. Evans, K. C., Berger, E. P., Cho, C.-G., Weisgraber, K. H., and Lansbury, P. T., Jr. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 763-767
37. Jarrett, J. T., and Lansbury, P. T., Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058
38. Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L.-M., Jakes, R., Alberts, M. J., Gilbert, J. R., Han, S.-H., Hulètte, C., Einstein, G., Schmechel, D. E., Pericak-Vance, M. A., and Roses, A. D. (1994) Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125, 163-171
39. Hamilton, R. L., Wong, J. S., Guo, L. S. S., Krisans, S., and Havel, R. J. (1990) Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J. Lipid Ret. 31, 1589-1603
40. Han, S.-H., Einstein, G., Weisgraber, K. H., Strittmatter, W. J., Saunders, A. M., Pericak-Vance, M., Roses, A. D., and Schmechel, D. E. (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53, 535-544
41. Askanas, V., Mirabella, M., Engel, W. K., Alvarez, R. B., and Weisgraber, K. H. (1994) Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet 343, 364-365
42. Handelmann, G. E., Boyles, J. K., Weisgraber, K. H., Mahley, R. W., and Pitas, R. E. (1992) Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neuntes by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33, 1677-1688
43. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., and Pitas, R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852
44. Nathan, B. P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R. W., and Pitas, R. E. (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270, 19791-19799
45. Nathan, B. P., Chang, K.-C., Bellosta, S., Mahley, R. W., and Pitas, R. E. (1995) The inhibition of neurite outgrowth by apolipoprotein E4 is mediated through the low density lipoprotein receptor-related protein. Soc. Neurosci. 21, 1009(abstr.)
46. Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., and Schwartz, A. L. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-depcndent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA 92, 9480-9484
47. Bellosta, S., Nathan, B. P., Orth, M., Dong, L.-M., Mahley, R. W., and Pitas, R. E. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270, 27063-27071
48. Mahley, R. W. In The Molecular and Genetic Basis of Neurological Disease (Rosenberg, R. N., Prusiner, S. B., DiMauro, S., and Barchi, R. L., eds) 2nd Ed, Butterworth Heinemann, Newton, Mass. In press
49. Herz, J., and Willnow, T. E. (1995) Lipoprotein and receptor interactions in vivo. Curr. Opin. Lipidol. 6, 97-103
50. Mahley, R. W., Ji, Z.-S., Brecht, W. J., Miranda, R. D., and He, D. (1994) Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann. N.Y. Acad. Sci. 737, 39-52
51. Ji, Z.-S., Fazio, S., Lee, Y.-L, and Mahley, R. W. (1994) Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269, 2764-2772
52. Ji, Z.-S., Fazio, S., and Mahley, R. W. (1994) Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J. Biol. Chem. 269, 13421-13428
53. Masliah, E., Mallory, M., Ge, N., Alford, M., Veinbergs, I., and Roses, A. D. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136, 107-122
54. Bird, T. D. (1995) Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view. Ann. Neurol. 38, 2-4
55. Mayeux, R., and Schupf, N. (1995) Apolipoprotein E and Alzheimer's disease: The implications of progress in molecular medicine. Am. J. Public Health 85, 1280-1284
56. Roses, A. D. (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38, 6-14
57. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease. (1995) Statement on use of apolipoprotein E testing for Alzheimer disease. J. Am. Med. Assoc. 274, 1627-1629
58. Poirier, J., Delisle, M.-C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., Gilfix, B. M., and Gauthier, S. (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 12260-12264